Conversion From Calcineurin Inhibitors to Everolimus With Low-Dose Cyclosporine in Renal Transplant Recipients With Squamous Cell Carcinoma of the Skin
β Scribed by Caroti, L.; Zanazzi, M.; Paudice, N.; Tsalouchos, A.; Carta, P.; Larti, A.; Pimpinelli, N.; Moscarelli, L.; Salvadori, M.; Bertoni, E.
- Book ID
- 119382634
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 86 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Chronic renal dysfunction is a frequent and severe complication in solid-organ transplant recipients. Calcineurin inhibitors (CNIs) are the main pathogenic factors of renal dysfunction. Switching from CNIs to nonnephrotoxic drugs, such as mammalian target of rapamycin inhibitors (everolimus and siro
Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin